NEOGENIX ONCOLOGY INC
CIK 0001341293
Revenue (TTM)
—
FY Jul 2012
Net Income (TTM)
−$19.13M
0.0% YoY
FY Jul 2012
EPS Diluted (TTM)
—
FY Jul 2012
Gross Margin
—
FY Jul 2012
Operating Margin
—
FY Jul 2012
Net Margin
—
FY Jul 2012
Free Cash Flow (TTM)
−$8.39M
FY Jul 2012
Cash
$2.99M
FY Jul 2012
Total Debt
$19.19K
FY Jul 2012
Shares Outstanding
22.92M sh
FY Jul 2012
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.